Avidity Biosciences, Inc. (RNA) NASDAQ
13.75
-0.8(-5.50%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
13.75
-0.8(-5.50%)
Currency In USD
| Market Cap | 9.93B |
| Enterprise Value | 9.65B |
| P/E Ratio | -2.77 |
| PEG Ratio | 0.15 |
| Price/Sales Ratio | 113.75 |
| Price/Book Ratio | 1.12 |
| Enterprise/Revenue | 98.39 |
| Enterprise/EBITDA | -2.61 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -36.5 |
| Operating Margin | -39.77 |
| Return On Assets | -0.35 |
| Return On Equity | -0.45 |
| Revenue | 18.76M |
| Revenue/Share | 0.14 |
| Gross Profit | 14.6M |
| EBITDA | -680.48M |
| Net Income | -684.63M |
| Diluted EPS | -4.97 |
| Total Cash | 1.7B |
| Total Cash/Share | 12.32 |
| Total Debt | 94.56M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 9.2 |
| Book Value Per Share | 12.26 |
| 52-Week Change | -55.8 |
| 52-Week High | 16.77 |
| 52-Week Low | 13.06 |
| Moving Average 50 Days | 14.97 |
| Moving Average 200 Days | 14.97 |
| Average Volume | 2.03M |
| Shares Outstanding | 155.15M |
| % Held by Institutions | 101.96 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |